TARGETED THERAPY

Clinical trials for TARGETED THERAPY explained in plain language.

Never miss a new study

Get alerted when new TARGETED THERAPY trials appear

Sign up with your email to follow new studies for TARGETED THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 1

New hope for advanced colon cancer: combo therapy targets tumors after standard treatment fails

Disease control Not yet recruiting

This study tests a new drug combination (SHR-1811 plus bevacizumab) as a second-line treatment for people with metastatic colorectal cancer that has worsened after initial chemotherapy. About 80 adults aged 18-75 will participate to see if the combo shrinks tumors or slows cancer…

Matched conditions: TARGETED THERAPY

Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control

Last updated May 01, 2026 15:57 UTC

TARGETED THERAPY

Get alerted when new TARGETED THERAPY trials appear

New hope for advanced colon cancer: combo therapy targets tumors after standard treatment fails